Blog - Page 9 of 11 - SOFIE

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging
Gallery
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

Christian Schmidkonz¹, Simon Rauber

jsctek_u4g7i52021-04-26T00:29:58+00:00November 5th, 2020|Publications|

SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing
Gallery
SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing

SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing

Dulles, VA, November 4, 2020 – SOFIE, whose vision is to improve patient outcomes […]

jsctek_u4g7i52021-05-19T01:04:55+00:00November 4th, 2020|News|

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?
Gallery
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?

Patrick Conen^1 2, Felix M […]

jsctek_u4g7i52021-04-26T00:30:50+00:00November 4th, 2020|Publications|

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient
Gallery
68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

Liang Zhao¹, Jianwei Gu²

jsctek_u4g7i52021-04-26T01:00:23+00:00October 3rd, 2020|Publications|

[ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer
Gallery
[ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

[ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

Jieling Zheng¹, Shaobo Yao²

Article available for purchase […]

jsctek_u4g7i52021-04-26T00:59:23+00:00August 10th, 2020|Publications|

Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
Gallery
Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Haojun Chen¹, Yizhen Pang¹,

jsctek_u4g7i52021-04-26T00:58:35+00:00July 29th, 2020|Publications|

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report
Gallery
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report

Yizhen Pang¹, Bing Hao,

jsctek_u4g7i52021-04-25T23:54:20+00:00July 24th, 2020|Publications|

68 Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation
Gallery
68 Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation

68 Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation

Ida Sonni¹, Stephanie Lee-Felker², Sanaz […]

jsctek_u4g7i52021-04-26T01:09:44+00:00July 10th, 2020|Publications|

Usefulness of [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [ 18 F]FDG PET/CT findings
Gallery
Usefulness of [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [ 18 F]FDG PET/CT findings

Usefulness of [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [ 18 F]FDG PET/CT findings

Haojun Chen^#¹,

jsctek_u4g7i52021-04-26T00:35:28+00:00June 25th, 2020|Publications|

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
Gallery
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease

“This FDA approval signals another important advancement in the evaluation of Alzheimer’s Disease. With […]

jsctek_u4g7i52021-05-19T01:05:37+00:00June 9th, 2020|News|

Previous 8910 Next

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others